Management Strategies for Refractory Localization‐Related Seizures
Open Access
- 1 July 2001
- Vol. 42 (s3) , 27-30
- https://doi.org/10.1046/j.1528-1157.2001.042suppl.3027.x
Abstract
Summary: Localization‐related epilepsy, the most common type of seizure disorder, often provides major management problems. Five new antiepileptic drugs (AEDs) with different mechanisms of action have been licensed in the United Kingdom in the 1990s for adjunctive use in the management of poorly controlled partial seizures. These were, in chronologic order, vigabatrin, lamotrigine, gabapentin, topiramate, and tiagabine. Their practical deployment is explored here. Mention also is made of clobazam and acetazolamide. Combination therapy with two or even three AEDs having complementary pharmacologic effects can provide an essential contribution to the management of partial seizures. This article discusses some of the pharmacologic strategies used in treating patients with refractory localization‐related epilepsy.Keywords
This publication has 21 references indexed in Scilit:
- Early Identification of Refractory EpilepsyNew England Journal of Medicine, 2000
- Lamotrigine and topiramate may be a useful combinationThe Lancet, 1998
- Polypharmacy with AnticonvulsantsCNS Drugs, 1997
- Lamotrigine substitution study: evidence for synergism with sodium valproate?Epilepsy Research, 1997
- Update on the Mechanism of Action of Antiepileptic DrugsEpilepsia, 1996
- Concentration‐Effect and Concentration‐Toxicity Relations with Lamotrigine: A Prospective StudyEpilepsia, 1996
- Vigabatrin and lamotrigine in refractory epilepsy.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Synergism with GABAergic drugs in refractory epilepsyThe Lancet, 1994
- Variability and clinical relevance of the interaction between sodium valproate and carbamazepine in epileptic patientsEpilepsy Research, 1992
- Factors relating to dramatic response to clobazam therapy in refractory epilepsyEpilepsy Research, 1988